Endo ends suit against FDA over compounding case 01-Oct-2019 By Ben Hargreaves After receiving a favorable outcome against rival compounders, Endo decides to drop its case against the FDA regarding its Vasostrict product.
Par recalls product after glass particulate contamination 13-May-2019 By Ben Hargreaves Par Pharmaceutical initiates a recall of mycophenolate mofetil injection, after a vial containing a glass fragment was discovered during reconstitution.